Sign In
Buy GH
$127.03
-3.14 (-2.41%)
At Close: Jun 03, 2026
PALO ALTO, Calif. & TAMPA, Fla.--(BUSINESS WIRE)--Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, and Meaningful Insights Biotech Analytics (MiBA), an innovative healthcare t
NEW YORK--(BUSINESS WIRE)--COTA Inc., a leader in real-world data (RWD) and analytics for oncology, announces a new partnership with leading precision oncology company Guardant Health Inc. (Nasdaq: GH
PALO ALTO, Calif.--(BUSINESS WIRE)--Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced a collaboration with Boehringer Ingelheim to pursue the regulatory approva
PALO ALTO, Calif.--(BUSINESS WIRE)--Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced the company and its research collaborators will present data demonstrating
Guardant Health Stock Flashing Surefire ‘Buy' Signal
01:31pm, Wednesday, 04'th Dec 2024
Biotechnology stock Guardant Health (GH) is trading at 15-month highs today, last seen up 7% at $38.28. Shares have added 107.7% over the last nine months, and now stand nearly 42% higher in 2024.
Guardant Health Secures One of the Largest False Advertising Verdicts in History, Representing a Significant Victory for Colorectal Cancer Patients Who Could Benefit from Guardant Reveal™ Natera F
Guardant Health Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
05:05pm, Wednesday, 13'th Nov 2024
PALO ALTO, Calif.--(BUSINESS WIRE)--Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced that on October 22, 2024, the Compensation Committee of Guardant's Board o
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought
11:55am, Tuesday, 12'th Nov 2024
The rock star money manager is starting to roll with the rallying market.
Guardant Health, Inc. (GH) Q3 2024 Earnings Call Transcript
09:53pm, Wednesday, 06'th Nov 2024
Guardant Health, Inc. (GH) Q3 2024 Earnings Call Transcript
Guardant Health (GH) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates
09:00pm, Wednesday, 06'th Nov 2024
Although the revenue and EPS for Guardant Health (GH) give a sense of how its business performed in the quarter ended September 2024, it might be worth considering how some key metrics compare with Wa
Guardant Health (GH) Reports Q3 Loss, Tops Revenue Estimates
07:21pm, Wednesday, 06'th Nov 2024
Guardant Health (GH) came out with a quarterly loss of $0.45 per share versus the Zacks Consensus Estimate of a loss of $0.55. This compares to loss of $0.73 per share a year ago.
Unveiling Guardant Health (GH) Q3 Outlook: Wall Street Estimates for Key Metrics
10:20am, Tuesday, 05'th Nov 2024
Evaluate the expected performance of Guardant Health (GH) for the quarter ended September 2024, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key
Why Guardant Health Stock Was the Picture of Health Today
06:52pm, Wednesday, 30'th Oct 2024
There's nothing like free publicity to help goose the sales of a relatively new product.
Will Guardant Health (GH) Report Negative Earnings Next Week? What You Should Know
11:07am, Wednesday, 30'th Oct 2024
Guardant Health (GH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Guardant Health Named to TIME's List of the Best Inventions of 2024
09:30am, Wednesday, 30'th Oct 2024
PALO ALTO, Calif.--(BUSINESS WIRE)--Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced the inclusion of its blood-based colorectal cancer screening product Shiel
